Apollo Hospitals Enterprise Ltd Share Price

Overview

Apollo Hospitals Enterprise Ltd share price is currently ₹8,646.68, down by - ₹17.26 (0.2%) from its previous closing price of ₹8,663.94. The share price has declined -0.77% over the past month and gained 12.38% over the past year. The stock's 52-week low and high are ₹0.00 and ₹9,055.69, respectively. Apollo Hospitals Enterprise Ltd has a market capitalisation of ₹ 1,30,000.00 Cr. The share price was last updated on 21 Aug 2026, 03:59 PM IST.

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

₹0.00

- ₹17.26

0.20%

Healthcare

₹0.00(%)1D

Updated: 21 Aug 2026, 03:59:15 pm IST

Market Data

Open Price

₹8,688.94

Prev. Close

₹8,663.94

₹8,591.21

Day Low

₹8,700.04

Day High

₹0.00

52 Week Low

₹9,055.69

52 Week High

HealthcareHospital & Healthcare Services

CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

59.51

Sector PE

42.16

PB Ratio

13.68

Sector PB

5.82

EPS

145.31

Dividend Yield

0.27

Today's Volume

183.316 K

5 Day Avg. Volume

318.724 K

PEG Ratio

1.74

Market Cap.

₹ 1,30,000.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 200% at ₹10/Share	14-Aug-2026	14-Aug-2026
DividendsInterim Dividend of 200% at ₹10/Share	16-Feb-2026	16-Feb-2026
DividendsFinal Dividend of 200% at ₹10/Share	19-Aug-2025	19-Aug-2025
DividendsInterim Dividend of 180% at ₹9/Share	14-Feb-2025	15-Feb-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
SBI Nifty 50 ETF	19.71 Lac	19.86 Lac (0.72%)
Axis Large Cap Fund - Regular Plan - Growth	10.41 Lac	10.41 Lac no change
HDFC Flexi Cap Fund - Growth	7.25 Lac	7.25 Lac no change
UTI Nifty 50 ETF	6.66 Lac	6.75 Lac (1.37%)
Axis Focused Fund - Regular Plan - Growth	6.68 Lac	6.68 Lac no change

Show all holdings

About Apollo Hospitals Enterprise Ltd 👋

Apollo Hospitals Enterprise Limited is an integrated healthcare company. It is engaged in the business of providing hospital services and selling pharma and wellness products through a network of pharmacies, including the operation of multidisciplinary private hospitals, clinics, diagnostic centers and pharmacies. It is engaged in hospitals and hospitals-based services. The Company's segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, and Others. The Retail Health and Diagnostics segment include clinics, diagnostics, Spectra, Cradle, Sugar, Dental and Dialysis business. The Digital Health and Pharmacy Distribution segment is engaged in the business of procurement and distribution of pharmaceuticals, fast-moving consumer goods and private label products business from various services using the digital platform. The Company has approximately 10,100 plus beds across 73 hospitals and 6,600 plus pharmacies.